Healthcare -
Biotechnology - NASDAQ - US
$ 7.58
-2.57 %
$ 162 M
Market Cap
-1.53
P/E
ENTA - OTHER LIABILITIES
Other Liabilities ENTA - Enanta Pharmaceuticals, Inc.
136 M
LAST VALUE
752.34%
2 YEAR CAGR
97.59%
5 YEAR CAGR
52.42%
10 YEAR CAGR